Skip to main content
. 2020 Jan 20;5(1):e002080. doi: 10.1136/bmjgh-2019-002080

Table 7.

Treatment CFRs for high-quality studies

# studies Pooled post-treatment CFR, % (95% CI) τ2
Overall 52 3.78 (2.77 to 5.16) 1.132
Adult 14 4.34 (2.65 to 7.12) 0.782
Paediatric 11 1.08 (1.06 to 1.10) 3.463
HIV− 6 1.93 (0.86 to 4.38) 0.706
HIV+ 7 12.17 (5.68 to 26.11) 0.782
Drug sensitive 34 3.94 (2.87 to 5.01) 0.739
Drug resistant 5 11.78 (2.96 to 46.78) 1.946
Public sector 52 3.78 (2.77 to 5.16) 1.132
Private sector 0